Clinical Trials Insight: 700012149

Trial Profile

Clinical Trials Insight: 700012149

Phase of Trial: Phase II

Latest Information Update: 02 Dec 2007

At a glance

  • Drugs Arimoclomol (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Adverse reactions
  • Sponsors CytRx Corporation
  • Most Recent Events

    • 02 Dec 2007 Additional trial results will be presented at the 18th Symposium on ALS/MND.
    • 15 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top